A structural basis for constitutive activity in the human CAR/RXRα heterodimer

被引:186
作者
Xu, RX [1 ]
Lambert, MH [1 ]
Wisely, BB [1 ]
Warren, EN [1 ]
Weinert, EE [1 ]
Waitt, GM [1 ]
Williams, JD [1 ]
Collins, JL [1 ]
Moore, LB [1 ]
Willson, TM [1 ]
Moore, JT [1 ]
机构
[1] GlaxoSmithKline, Discovery Res, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1016/j.molcel.2004.11.042
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The X-ray crystal structure of the human constitutive androstane receptor (CAR, NR1I3)/retinoid X receptor a (RXRalpha, NR2B1) heterodimer sheds light on the mechanism of ligand-independent activation of transcription by nuclear receptors. CAR contains a single-turn Helix X that restricts the conformational freedom of the C-terminal AF2 helix, favoring the active state of the receptor. Helix X and AF2 sit atop four amino acids that shield the CAR ligand binding pocket. A fatty acid ligand was identified in the RXRalpha binding pocket. The endogenous RXRalpha ligand, combined with stabilizing interactions from the heterodimer interface, served to hold RXRalpha in an active conformation. The structure suggests that upon translocation, CAR/RXRalpha heterodimers are preorganized in an active conformation in cells such that they can regulate transcription of target genes. Insights into the molecular basis of CAR constitutive activity can be exploited in the design of inverse agonists as drugs for treatment of obesity.
引用
收藏
页码:919 / 928
页数:10
相关论文
共 60 条
[1]   A NEW ORPHAN MEMBER OF THE NUCLEAR HORMONE-RECEPTOR SUPERFAMILY THAT INTERACTS WITH A SUBSET OF RETINOIC ACID RESPONSE ELEMENTS [J].
BAES, M ;
GULICK, T ;
CHOI, HS ;
MARTINOLI, MG ;
SIMHA, D ;
MOORE, DD .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) :1544-1552
[2]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[3]  
BARRIERENMACKEN.A, 2003, GENE DEV, V17, P3036
[4]   Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains [J].
Bourguet, W ;
Vivat, V ;
Wurtz, JM ;
Chambon, P ;
Gronemeyer, H ;
Moras, D .
MOLECULAR CELL, 2000, 5 (02) :289-298
[5]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[6]   In-line desalting mass spectrometry for the study of noncovalent biological complexes [J].
Cavanagh, J ;
Benson, LM ;
Thompson, R ;
Naylor, S .
ANALYTICAL CHEMISTRY, 2003, 75 (14) :3281-3286
[7]   Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR [J].
Choi, HS ;
Chung, MR ;
Tzameli, I ;
Simha, D ;
Lee, YK ;
Seol, W ;
Moore, DD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (38) :23565-23571
[8]  
Devchand PR, 1999, ADV EXP MED BIOL, V469, P231
[9]   A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity [J].
Dussault, I ;
Lin, M ;
Hollister, K ;
Fan, M ;
Termini, J ;
Sherman, MA ;
Forman, BM .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (15) :5270-5280
[10]   Androstane metabolites bind to and deactivate the nuclear receptor CAR-β [J].
Forman, BM ;
Tzameli, I ;
Choi, HS ;
Chen, L ;
Simha, D ;
Seol, W ;
Evans, RM ;
Moore, DD .
NATURE, 1998, 395 (6702) :612-615